Commercial License Request Forms under Subscription and License Agreement between OncoMed Pharmaceuticals, Inc. and MorphoSys AG

Summary

This document contains commercial license request forms executed by OncoMed Pharmaceuticals, Inc. and MorphoSys AG under their Subscription and License Agreement. The forms are used to request commercial therapeutic licenses for specific targets, as defined in the agreement. Each form is signed by authorized representatives of both companies and includes details about the requested target and license type. Some information has been omitted for confidentiality. The forms also allow MorphoSys to indicate whether a clinical monitoring license is included.

EX-10.3(B) 16 d344523dex103b.htm COMMERCIAL LICENSE REQUESTS UNDER THE SUBSCRIPTION AND LICENSE AGREEMENT Commercial License Requests under the Subscription and License Agreement

Exhibit 10.3(B)

Execution Version

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

APPENDIX 4.3(a)

COMMERCIAL LICENSE REQUEST FORM

(To be completed for each Commercial Target)

Target requested pursuant to Section 4.3 of the Subscription and License Agreement (define: by common name(s), accession number, and amino acid sequence, if possible):

[***]

Type of Commercial License Requested: Commercial Therapeutic License


ONCOMEDPHARMACEUTICALS, INC.		MORPHOSYS AG

By:	/s/ John A. Lewicki	By:	/s/ I.A. Christine Rothe

Name:	John A. Lewicki	Name:	Christine Rothe

Title:	SR VP, R&D	Title:	Senior Manager, Alliance Manager

Date:	28^thApril, 2008	Date:	6^thMay 2008

		MORPHOSYS AG

		By:	/s/ Harald Watzka

		Name:	Harald Watzka

		Title:	Director, Head of AM

		Date:	6^thMay 2008

[to be filled out by MORPHOSYS:] Does the Commercial License include a Clinical Monitoring License? (please circle) [***]